Let-7 contributes to the regulation of several signaling pathways, such as breast cancer cell growth, the regulation of MYC expression, and the regulation of CSC properties [46,47], and could be a potential therapeutic target for breast cancer patients. This evidence concerns the gene MYC and breast cancer.